Predictors for ACS and Complexity of CAD
Launched by ASSIUT UNIVERSITY · Aug 12, 2025
Trial Information
Current as of August 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether certain blood fat measurements—the Triglyceride index and the ratio of triglycerides to "good" cholesterol (called HDL)—can help predict the risk of sudden heart problems, known as acute coronary syndromes, in young adults. The goal is to understand if these blood tests can give early warning signs for heart issues in people aged 18 to 40 who have already been diagnosed with these conditions.
If you are between 18 and 40 years old, have recently had a type of heart attack or similar heart problem, and are willing to take part, you might be eligible for this study. People over 40, those who have had previous heart attacks, or those with inherited cholesterol problems cannot join. Participants will be asked to give their consent and may have blood tests and other assessments to help researchers learn more about how these fat levels relate to heart health in younger people. The study is not yet recruiting, but it hopes to provide useful information that could improve early detection and care for heart conditions in young adults.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • -
- • Age 18-40 years. Confirmed diagnosis of ACS (STEMI, NSTEMI). Willingness to participate with informed consent.
- Exclusion Criteria:
- • Age \> 40 years old People with Previous ACS Patients known to have familial hyperlipidemia
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Khaled Mohamed Abdallah, Professor
Study Director
Assuit university - faculty of medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported